Gluzman D.F., Zinchenkо V.N., Ivanivska T.S., Pidgorna О.О., Polishchuk А.S., Sklyarenko L.М.

Blastoid variant (BV) constitutes about 30% of all histopathological subtypes of mantle cell lymphoma (MCL). It is very difficult to diagnose blastoid variant of mantle cell lymphoma (MCL-BV) on the basis of cytomorphology alone. MCL-BV with leukemic presentation mimics lymphoblastic lymphoma, centroblastic large cell lymphoma, acute lymphoblastic leukemia and some types of acute myeloid leukemia. Objective: to define cytomorphological and immunophenotypical criteria for diagnosing MCL-BV in the setting of the appearance of pathological cells in peripheral blood and the development of the infiltration foci in bone marrow. Object and methods: immynophenotyping and flow cyto­metry of neoplastic cell in 55 patients with classic mantle cell lymphoma and in 9 cases of MCL-BV with leukemic presentation were studied. Results: peripheral blood smears in most cases leukocytosis (60–130•109/l) along with 50–90% abnormal blast or blast-line cells. On bone marrow examination the high level of cells also were seen. The abnormal blood and bone marrow cells of four patients with MCL-BV were: CD19+CD20+CD5+CD10CD23Cyclin D1+. Five patients have aberrant phenotype of blast-line cells in the form of anomal expression CD5, CD10, CD19 antigenes. Cyclin D1 expression confirmed the diagnosis of MCL-BV in all patients. Conclusion: the results of cytomorphological, enzymocytochemical studies and immunophenotyping using the panel of specially selected MABs allow identification of the blood and bone marrow substrate cells in the MCL-BV in the stage of leukemia, and conduct differential dia­gnosis with other forms of non-Hodgkin’s lymphomas and acute leukemias of lymphoid and myeloid origin.

DOI: 10.32471/oncology.2663-7928.t-21-2-2019-g.7357

No comments » Add comment